(Q51763129)
Statements
Advanced glycation end products contribute to the immunogenicity of IFN-β pharmaceuticals. (English)
1 reference
Angelina Bozhinov
1 reference
Yordan Handzhiyski
1 reference
Krasimir Genov
1 reference
Vera Daskalovska
1 reference
Toshimitsu Niwa
1 reference
Ivan Ivanov
1 reference
Roumyana Mironova
1 reference
9 December 2011
1 reference
129
1 reference
3
1 reference
855-858.e6
1 reference